The future insights of AI Applications in Hematology diseases diagnosis and prognosis: Review Article

Artificial intelligence (AI) is rapidly altering the field of hematology, providing novel approaches to diagnosis, prognosis, and management of hematological illnesses. AI technologies, including machine learning (ML) and deep learning (DL), allow for the analysis of massive volumes of clinical, genetic, and imaging data, resulting in more accurate, rapid, and individualized care. In diagnostic hematology, AI is transforming blood smear analysis, bone marrow aspirations, and genomic profiling by automating cell classification, detecting anomalies, and discovering critical genetic changes associated with blood illnesses. AI-powered models are also improving prognostic skills by predicting disease progression, treatment response, and risk of relapse in illnesses such as leukemia, lymphoma, anemia, and myeloproliferative disorders. Furthermore, AI applications in precision medicine enable clinicians to adapt medicines based on individual genetic profiles, thereby increasing therapeutic success and reducing unwanted effects. The combination of AI and modern technology such as wearable health monitors and real-time diagnostic tools promises to improve patient management by providing proactive care via continuous monitoring and adaptive treatment options. As AI develops, it has enormous potential in hematology, enabling early identification, optimizing treatment regimens, and ultimately improving patient survival and quality of life. This study investigates the future implications of AI applications in hematology, emphasizing their revolutionary impact on diagnosis, prognosis, and individualized treatment techniques.